Person

Jonathan Monson

EVP and CFO, Boston Scientific

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$1.4M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 31, 2023BSXSale5,000$50.00$250K
Mar 1, 2023BSXSale5,000$46.66$233K
Jun 16, 2021BSXSale8,833$42.76$378K
Jun 15, 2021BSXSale7,901$42.78$338K
Jun 14, 2021BSXSale5,000$42.94$215K

SEC reporting-owner ID (CIK) 1779170 · all filings on EDGAR